10-Q: Universal Health Realty Reports Q2 Profit Decline Amid Rising Costs

Universal Health Realty Income Trust reported a decrease in net income and FFO for the second quarter and first half of 2025, primarily due to increased interest expense and a non-recurring property tax reduction benefit in the prior year, alongside new legislative risks impacting tenant revenues.

Summary

• Net income for the three months ended June 30, 2025, decreased by $784,000 to $4.492 million, compared to $5.276 million in the prior year.
• Basic earnings per share declined to $0.33 for Q2 2025 from $0.38 in Q2 2024, while diluted EPS fell to $0.32 from $0.38.
• Revenues for the three months ended June 30, 2025, slightly increased by $134,000 to $24.868 million, up from $24.734 million in Q2 2024.
• Funds From Operations (FFO) decreased by $591,000 to $11.794 million for Q2 2025, down from $12.385 million in Q2 2024.
• FFO per diluted share was $0.85 for Q2 2025, a decrease from $0.90 in Q2 2024.
• For the six months ended June 30, 2025, net income decreased by $1.3 million to $9.269 million, and revenues decreased by $459,000 to $49.416 million.
• Net cash provided by operating activities increased by $1.4 million to $25.3 million for the six months ended June 30, 2025.
• The Credit Agreement's maturity date was extended to September 30, 2028, and its aggregate borrowing capacity increased to $425 million from $375 million as of September 30, 2024.
• As of June 30, 2025, $70.2 million of borrowing capacity was available under the Credit Agreement.
• Dividends declared and paid were $0.740 per share in Q2 2025 ($10.3 million) and $1.475 per share for the six months ended June 30, 2025 ($20.5 million).
• A shelf registration statement (Form S-3) for up to $100 million of securities became effective on April 30, 2024, but no shares have been issued under it through June 30, 2025.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to declining net income, EPS, and FFO, coupled with a significant new legislative risk that is expected to unfavorably impact tenant revenues and increase uncompensated care. While operating cash flow improved and liquidity is managed, the core profitability metrics are trending downwards, and future regulatory changes pose substantial uncertainty for the business model.

Positives

• Net cash provided by operating activities increased by $1.4 million to $25.3 million for the six months ended June 30, 2025, demonstrating improved operational cash generation.
• The Credit Agreement's maturity was extended to September 30, 2028, and its borrowing capacity increased to $425 million, enhancing liquidity and financial flexibility.
• The company remains in compliance with all covenants in its Credit Agreement as of June 30, 2025, indicating sound financial management and debt servicing capability.
• The average effective cost of borrowings under the credit agreement decreased to 5.93% in Q2 2025 from 6.92% in Q2 2024, reducing financing costs.
• The company maintains a healthy dividend payout, with $0.740 per share declared for Q2 2025, a slight increase from $0.730 per share in Q2 2024.

Negatives

• Net income decreased by $784,000 (14.86%) for the three months ended June 30, 2025, and by $1.3 million (12.36%) for the six months, primarily due to increased interest expense and a non-recurring property tax reduction in the prior year.
• Basic and diluted earnings per share declined for both the three and six-month periods ended June 30, 2025.
• Funds From Operations (FFO) decreased by $591,000 (4.77%) for the three months and $1.1 million (4.33%) for the six months ended June 30, 2025.
• Revenues for the six months ended June 30, 2025, decreased by $459,000 (0.92%), primarily due to decreased occupancy rates at certain Medical Office Buildings (MOBs).
• Interest expense, net, increased by $137,000 for the three months and $259,000 for the six months ended June 30, 2025, largely due to a net decrease in interest rate swap income.
• Total equity decreased by $14.389 million (8.01%) from December 31, 2024, to June 30, 2025.
• Available borrowing capacity decreased by $5.9 million to $70.2 million as of June 30, 2025, from $76.1 million at December 31, 2024.

Risks

• A substantial portion of revenues (approximately 40%) is dependent upon one operator, Universal Health Services, Inc. (UHS), and there is no assurance that UHS subsidiaries will renew leases or that favorable returns will be earned if purchase options are exercised.
• Increased interest rates have significantly raised interest expense, reducing net income, cash from operations, and FFO, and may unfavorably impact access to capital markets and future investments.
• New legislation, the 'One Big Beautiful Bill Act' (July 4, 2025), attaches work and community service requirements to Medicaid eligibility, limits provider fees, and eliminates certain insurance exchange premium tax credits beyond 2025, which is expected to reduce operator revenues and increase uncompensated care, unfavorably impacting results.
• Tenants have experienced inflationary pressures, particularly in personnel and other costs, and staffing shortages, which could impact their ability and willingness to make rental payments if reimbursement rates do not keep pace.
• Increased competition/capacity and decreases in occupancy and rental rates in certain real estate markets may adversely impact operating results and property values.
• Major changes in the healthcare delivery system due to legislative initiatives could materially adversely affect the business, financial condition, or results of operations of operators.
• The relationship with UHS, where a subsidiary is the Advisor and officers are UHS employees, may create potential conflicts of interest.
• Potential unfavorable tax consequences and reduced income from an inability to complete tax-deferred like-kind exchange transactions.
• Deterioration in national, regional, and local economic conditions, including credit and capital market conditions, could adversely affect the ability to obtain capital for growth and debt refinancing.
• Heightened risk of future cybersecurity threats, including ransomware attacks, could result in significant costs, penalties, litigation, and reputational damage.
• The outcome and effects of known and unknown litigation, government investigations, and regulatory actions against the company, UHS, or other operators.
• Failure of UHS or other operators to comply with governmental regulations related to Medicare and Medicaid licensing and certification requirements could materially adversely impact future revenues and property values.
• Real estate market factors, including supply and demand, changes in interest rates, and increased development of medical office condominiums, could negatively affect property values and operating results.
• The impact of severe weather conditions, including hurricanes, on property values and results of operations.
• Government regulations, including potential reductions to Medicare and Medicaid funding levels, could negatively impact tenants' ability to make rental payments.
• New tariffs could adversely impact the business and financial condition of the company and its tenants due to increased costs.
• Challenges in the healthcare industry, such as changes in laws, unfavorable reimbursement terms, demographic shifts, and the ability to attract and retain medical personnel, affect operators.
• The Budget Control Act of 2011's Medicare payment reductions, extended through 2032, could unfavorably impact operators and the company's business.
• Uncertainty regarding future legislative changes to the Affordable Care Act (ACA) and its impact on healthcare delivery and reimbursement.
• Potential material unfavorable impact from a federal government shutdown on the operating results of tenants and, consequently, the company.
• Competition for properties from other REITs, private investors, banks, and other companies, including UHS, and competition for tenants.
• Changes in, or inadvertent violations of, tax laws and regulations affecting REIT status.
• Inability to comply with REIT income distribution requirements using only operating cash, potentially requiring other cash sources.
• Fluctuations in the value of common stock, potentially affected by changes in the interest rate environment.
• The existence of buy/sell options within unconsolidated LLC/LP agreements, allowing partners to force a sale or purchase of ownership interests.

Future Outlook

Management expects to finance all capital expenditures, acquisitions, and pay dividends using internally generated funds and additional capital. Additional funds may be sourced from the $425 million Credit Agreement (with $70.2 million available as of June 30, 2025), borrowings or refinancing of existing third-party debt, issuance of other long-term debt, and/or issuance of equity under the $100 million shelf registration statement. The company believes its operating cash flows, cash and cash equivalents, available borrowing capacity, and access to capital markets will provide sufficient resources for the next twelve months, including maintaining REIT status. However, there is no assurance that financing will be obtained on acceptable terms or within an acceptable time, which could materially unfavorably impact results.

Management Comments

• Management routinely monitors and analyzes the Trust's capital structure to maintain a targeted balance among capital resources, including revolving credit, non-recourse mortgage debt, and equity.
• The ongoing analysis considers factors such as the current debt market, interest rate environment, property occupancy and financial performance, loan-to-value ratios, stock price, anticipated acquisitions, and expected divestiture proceeds.
• Management and the Board of Trustees determine dividend levels quarterly, considering the minimum required for REIT status, current and projected operating results, and future capital commitments and debt repayments.
• Operating cash flows have been sufficient to fund dividend payments, and future dividend levels will be determined based on projected future results of operations.

Industry Context

The healthcare real estate industry faces significant headwinds from legislative changes, particularly the 'One Big Beautiful Bill Act' enacted on July 4, 2025. This legislation, by limiting Medicaid enrollment and expenditures, reducing provider fees, and eliminating certain insurance exchange premium tax credits, is expected to decrease revenues for healthcare operators and increase uncompensated care. This directly impacts REITs like Universal Health Realty Income Trust, which derive substantial revenue from leasing facilities to these operators. The industry also continues to grapple with inflationary pressures on personnel and other costs, staffing shortages, and increased competition in certain markets, which can affect occupancy rates and rental income. While interest rates have moderated, their previous increases continue to impact financing costs across the sector. The ongoing evolution of healthcare regulations and reimbursement models remains a critical factor for the stability and growth of healthcare REITs.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or industry benchmarks for financial performance, making a direct comparison challenging.
• The advisory fee computation remained unchanged for 2025 compared to 2024 and 2023, based on a review against an unspecified 'industry peer group', suggesting the fee structure is considered competitive or appropriate within its segment.
• The company's total leverage ratio of 43.8% at June 30, 2025, and fixed charge coverage ratio of 3.1x are within the Credit Agreement's covenants (<=60% and >=1.50x, respectively), which generally aligns with prudent financial management for REITs, though specific industry averages for healthcare REITs would provide more granular context.

Corporate Governance

Legal Proceedings

• UHS and its subsidiaries are subject to legal actions, purported shareholder class actions, shareholder derivative cases, governmental investigations, and regulatory actions. Since UHS comprises approximately 40% of consolidated revenues and a subsidiary of UHS is the Advisor, investors are encouraged to review UHS's public filings for details on these matters.

Related Party Transactions

• A wholly-owned subsidiary of UHS (UHS of Delaware, Inc.) serves as the Advisor under an annually renewable Advisory Agreement, renewed for 2025 with the same terms as 2024 and 2023.
• Officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc.
• Five hospital facilities are leased to wholly-owned subsidiaries of UHS, and one hospital facility is leased to a joint venture between a wholly-owned subsidiary of UHS and a third party.
• Subsidiaries of UHS are tenants of twenty medical/office buildings or free-standing emergency departments, either wholly or jointly-owned.
• Aggregate revenues generated from UHS-related tenants comprised approximately 40% of consolidated revenues during the three and six-month periods ended June 30, 2025, and 41% during the comparable periods of 2024.
• Financing receivables from UHS related to an asset purchase and sale agreement totaled $82.5 million as of June 30, 2025.
• UHS has various options to renew leases or purchase leased facilities (McAllen Medical Center, Wellington Regional Medical Center, Aiken Regional Medical Center, Canyon Creek Behavioral Health) at the end of lease terms or upon certain conditions.
• UHS-related joint venture has options to renew or purchase Clive Behavioral Health Hospital.
• Two wholly-owned subsidiaries of UHS exercised 5-year renewal options on two FEDs in Weslaco and Mission, Texas, covering February 1, 2025, through January 31, 2030.
• McAllen Doctor's Center is 100% master leased to McAllen Hospitals, L.P., a wholly-owned subsidiary of UHS, with an annual base rent of approximately $643,000.
• A ground lease and master flex-lease agreement for Sierra Medical Plaza I MOB were entered into with a wholly-owned subsidiary of UHS.
• The company is the lessee on thirteen ground leases with subsidiaries of UHS (for consolidated and unconsolidated investments).
• Advisory fees incurred and paid to UHS amounted to approximately $1.4 million for each of the three-month periods ended June 30, 2025 and 2024, and approximately $2.8 million and $2.7 million for the six-month periods ended June 30, 2025 and 2024, respectively.
• As of June 30, 2025, UHS owned 5.7% of the company's outstanding shares of beneficial interest.

Stakeholder Impact

• **Shareholders**: Experience decreased net income, EPS, and FFO, potentially impacting future share price and dividend growth, despite current dividend stability. The new legislative risks could create long-term uncertainty.
• **Tenants (especially UHS subsidiaries)**: Face reduced revenues and increased uncompensated care due to the 'One Big Beautiful Bill Act' and ongoing inflationary pressures and staffing shortages, which could strain their ability to meet lease obligations.
• **Employees (UHS employees serving as officers)**: Continue to receive stock-based compensation awards, aligning their interests with the company's performance.
• **Creditors**: The company remains in compliance with all debt covenants, and the credit facility maturity extension provides stability, which is positive for creditors.
• **Customers (patients of facilities)**: May be impacted by changes in Medicaid eligibility and insurance exchange subsidies, potentially affecting access to care or increasing out-ofpocket costs.

Next Steps

• Continue marketing the vacant land in Chicago, Illinois, and the vacant specialty facility in Evansville, Indiana, to third parties.
• Monitor the impact of the 'One Big Beautiful Bill Act' on Medicaid eligibility, provider fees, and insurance exchange premium tax credits, and its effect on operator revenues and uncompensated care.
• Evaluate the impact of ASU 2024-03, 'Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures,' on related financial statement disclosures, effective for fiscal years beginning after December 15, 2026.
• Management will continue to monitor and analyze the capital structure to maintain a targeted balance among capital resources.
• Future dividend levels will be determined based on projected future results of operations and other factors.

Key Dates

Recommendation

The company's Q2 2025 results show a decline in key profitability metrics (net income, EPS, FFO) and a slight revenue decrease for the six-month period, which are concerning. Furthermore, the newly enacted 'One Big Beautiful Bill Act' poses a significant future headwind for the company's tenants, potentially reducing their revenues and increasing uncompensated care, directly impacting Universal Health Realty Income Trust's long-term prospects. While the company has managed to increase operating cash flow, extend its credit facility, and remains compliant with debt covenants, these positives are overshadowed by the deteriorating profitability and substantial regulatory risk. For a seasoned investor, a 'hold' recommendation is appropriate to monitor the actual impact of the legislative changes on tenant performance and the company's ability to mitigate these challenges, rather than a 'sell' which might be premature given the current liquidity and dividend stability.

Keywords

Healthcare REIT, Real Estate Investment Trust, Medical Office Buildings, Hospitals, Behavioral Health, SEC Filing, 10-Q, Financial Results, Earnings, FFO, Dividends, Debt, Credit Agreement, Interest Rates, Medicaid, ACA, Risk Factors, UHS, Universal Health Services